MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12887-026-06667-z

Медицинская библиотека · BMC pediatrics · 2026

Single-center analysis of relapse risk factors and prognosis in 256 cases of ETV6::RUNX1-positive pediatric acute lymphoblastic leukemia.

Hu Binglian, Hu Fangzhou, He Hailong, Kong Lingjun

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, and although ETV6::RUNX1–positive B-cell ALL generally carries a favorable prognosis, it has a notable risk of late relapse. This study aimed to identify key relapse-associated risk factors and evaluate their impact on survival outcomes in children with ETV6::RUNX1–positive ALL.

METHODS

We performed a retrospective cohort study including 256 pediatric patients diagnosed with ETV6::RUNX1–positive ALL at the Children’s Hospital of Soochow University between May 2008 and August 2020. Clinical characteristics, treatment responses, and relapse patterns were assessed. Independent predictors of relapse were identified using multivariate logistic regression, and survival outcomes were analyzed using the Kaplan–Meier method.

RESULTS

Elevated initial white blood cell (WBC) count (≥ 50 × 10⁹/L), poor steroid response at day 7, and persistence of the ETV6::RUNX1 fusion transcript at the first post-therapy minimal residual disease assessment were significant independent predictors of relapse (P < 0.05). Among relapsed patients, early relapse (within 36 months of diagnosis) and lack of hematopoietic stem cell transplantation (HSCT) were associated with markedly inferior survival (5-year overall survival (OS): 17.6% vs. 55.6%, P = 0.006).

CONCLUSIONS

This study identifies three critical risk factors for relapse in ETV6::RUNX1–positive pediatric ALL and highlights the adverse prognostic impact of early relapse. Importantly, the persistent detection of ETV6::RUNX1 fusion transcript at initial minimal residual disease (MRD) evaluation emerged as a novel and independent biomarker for early risk stratification. These findings may guide refinement of individualized therapeutic strategies to improve long-term outcomes in this pediatric subgroup.

Для цитирования: Hu Binglian, Hu Fangzhou, He Hailong, Kong Lingjun. Single-center analysis of relapse risk factors and prognosis in 256 cases of ETV6::RUNX1-positive pediatric acute lymphoblastic leukemia.. BMC pediatrics. 2026. DOI: 10.1186/s12887-026-06667-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.